File:Tirzepatide.jpg
From WikiAlpha
Size of this preview: 600 × 600 pixels. Other resolutions: 240 × 240 pixels | 768 × 768 pixels.
Original file (768 × 768 pixels, file size: 45 KB, MIME type: image/jpeg)
Tirzepatide is a synthetic derivative that combines the functionalities of gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). This unique combination enables Tirzepatide to effectively lower blood glucose levels, improve insulin sensitivity, promote feelings of satiety, and facilitate weight loss. Initially developed as a treatment for type 2 diabetes, Tirzepatide has also demonstrated the ability to protect the cardiovascular system and act as a potent agent for weight loss.
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment | |
|---|---|---|---|---|---|
| current | 06:33, 26 May 2023 | | 768 × 768 (45 KB) | Aea.ltd (Talk | contribs) | Tirzepatide is a synthetic derivative that combines the functionalities of gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). This unique combination enables Tirzepatide to effectively lower blood glucose levels, improve insulin... |
- You cannot overwrite this file.
File usage
The following 2 pages link to this file:
